External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting-Reference-Cited by-同舟云学术

External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting

Published:2017-03 Issue:3 Volume:20 Page:397-403
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Hoogendoorn Martine,Feenstra Talitha L.,Asukai Yumi,Briggs Andrew H.,Hansen Ryan N.,Leidl Reiner,Risebrough Nancy,Samyshkin Yevgeniy,Wacker Margarethe,Rutten-van Mölken Maureen P.M.H.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference29 articles.

1. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease;Borg;Value Health,2004

2. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease;Spencer;Pharmacoeconomics,2005

3. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease;Hoogendoorn;Value Health,2011

4. Modeling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain;Rutten-van Molken;Eur J Health Econ,2007

5. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients;Dal;Int J Chron Obstruct Pulmon Dis,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada – The IMPACT trial;Respiratory Medicine;2024-09

2. Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke;Journal of Neurosurgery;2023-01-01

3. Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial;International Journal of Chronic Obstructive Pulmonary Disease;2022-12

4. Cost‐effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross‐comparison challenge;Alzheimer's & Dementia;2022-10-25

5. Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD;Respiratory Medicine;2022-08